Company Profile
Kura Oncology Stock Price, News & Analysis
- Ticker:
- KURA
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Kura Oncology is followed within the oncology universe where readouts and regulatory timing often dominate the stock.
Stock performance
10.38 USD (+0.19%)
Close
Last updated: June 23, 2026 at 00:00
921.48M USD
Market cap
Why the stock is moving
KURA is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Kura Oncology is an oncology-focused biopharmaceutical company centered on cancer programs, with investors watching clinical data, regulatory milestones, and the commercial path for its lead assets.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Kura Oncology is followed within the oncology universe where readouts and regulatory timing often dominate the stock.
Business Model Characteristics
Kura Oncology follows a pipeline-and-commercial model where investors track trial execution, launch cadence, and the pace at which oncology data can be turned into durable product value.
Position Within the Biotechnology Landscape
Compared with larger diversified peers, Kura Oncology sits in a high-catalyst corner of the biotech landscape, where oncology updates can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
- 03
- 04
- 05
Kura Oncology to Present at TD Cowen 7th Annual Oncology Innovation Summit
Source: Kura Oncology
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Kura Oncology (KURA)?
Kura Oncology (KURA) most recently closed at 10.38 USD, a +0.19% move versus the previous session.
What is the market cap of Kura Oncology (KURA)?
Kura Oncology currently has a market capitalization of 921.48M USD on BioPharmSignal.
What does Kura Oncology do?
Kura Oncology is an oncology-focused biopharmaceutical company centered on cancer programs, with investors watching clinical data, regulatory milestones, and the commercial path for its lead assets.
On which exchange is KURA stock listed?
Kura Oncology (KURA) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Kura Oncology is followed within the oncology universe where readouts and regulatory timing often dominate the stock., Biotechnology.
What is Kura?
Kura Oncology is an oncology-focused biopharmaceutical company centered on cancer programs, with investors watching clinical data, regulatory milestones, and the commercial path for its lead assets.
Which conditions is Kura Oncology targeting with Kura?
Kura Oncology is associated with oncology, cancer therapeutics based on its company overview and current catalyst commentary.
What is Oncology?
Kura Oncology is an oncology-focused biopharmaceutical company centered on cancer programs, with investors watching clinical data, regulatory milestones, and the commercial path for its lead assets.